Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
Mitochondrial connection to Alzheimer's disease and heart failure
Anupriya Sinha1, Natasha Jaiswal2, Pooja Jadiya2,3
1Department of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Insights
The brain and heart are linked; problems in one affect the other. Mitochondrial dysfunction is a key factor in both Alzheimer's disease (AD) and cardiovascular diseases (CVDs), suggesting new therapy targets.
Area of Science:
- Neuroscience
- Cardiology
- Mitochondrial Biology
Background:
- The brain and heart exhibit a strong interdependence, where dysfunction in one organ system can precipitate issues in the other.
- Cardiovascular diseases (CVDs), such as heart failure, can compromise cerebral blood flow, leading to cognitive impairment and elevated dementia risk.
- Alzheimer's disease (AD), characterized by specific neuropathological hallmarks, has been observed to negatively affect cardiac function.
Purpose of the Study:
- To explore the intricate relationship between brain and heart health.
- To investigate the shared role of mitochondrial dysfunction in the pathogenesis of both Alzheimer's disease and cardiovascular diseases.
- To highlight the therapeutic potential of targeting mitochondrial pathways for co-treating neurodegenerative and cardiovascular conditions.
Main Methods:
- Review of existing literature on the interplay between cardiovascular and neurological systems.
- Analysis of shared molecular and cellular mechanisms, focusing on mitochondrial function.
- Examination of the impact of AD and CVD on organ-specific pathologies.
Main Results:
- Evidence indicates that impaired cerebral blood flow in CVDs contributes to cognitive decline and dementia.
- Alzheimer's disease pathology is associated with detrimental effects on cardiac function.
- Mitochondrial dysfunction emerges as a critical common pathway, exacerbating both neurodegeneration in AD and cardiac issues in CVDs.
Conclusions:
- The brain-heart axis is a critical determinant of overall health, with bidirectional influences.
- Mitochondrial dysfunction is a pivotal shared mechanism underlying Alzheimer's disease and cardiovascular diseases.
- Targeting mitochondrial health presents a promising therapeutic avenue for simultaneously addressing neurodegenerative and cardiovascular diseases, particularly in an aging population.
Abstract:
The brain and heart are intricately linked, with dysfunction in one organ often affecting the other. Cardiovascular diseases (CVDs), particularly heart failure, impair cerebral blood flow, contributing to cognitive decline and increasing dementia risk. Conversely, Alzheimer's disease (AD), marked by amyloid-beta plaques and tau tangles, impacts cardiac function. A shared mechanism between AD and CVDs is mitochondrial dysfunction, which disrupts energy production and oxidative balance, worsening both neurodegeneration and heart health. This interdependence underscores the potential for mitochondria-targeted therapies to address both conditions. With an aging population facing rising incidences of AD and CVDs, understanding these interconnected pathways and the central role of mitochondria could inform new therapeutic strategies and improve outcomes in both neurodegenerative and cardiovascular diseases.
Related Concept Videos
Mitochondria
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Heart Failure II: Pathophysiology
Alzheimer's Disease: Treatment
Pathophysiology of Heart Failure

